United Industries focuses on medtech future:
This article was originally published in Clinica
United Industries (UI) has sold its industrial components and systems division for £6.2 million ($8.9 million) to focus on its medtech sector interests. The disposal, assisted by consultancy NMB Heller, narrows its commitments down to three technical plastics businesses: orthopaedic implants company Perplas, Hi Tech House, which specialises in plastic hoses for medical applications and thermoset and thermoplastic bearings company Railcko. Sul Sahota, UI's new CEO, would not reveal the company's market performance but reported the company's prospects this year as 'interesting'.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.